<DOC>
	<DOCNO>NCT01728337</DOCNO>
	<brief_summary>study propose provide scientific objective data clinical aesthetic effect two toxin ( Dysport Xeomin ) .</brief_summary>
	<brief_title>Phase Iv Study On Muscle Activity Of Two Commercial Preparations Of Botulinum</brief_title>
	<detailed_description>Subjects perform 6 ( six ) visit study : Screening visit , perform 30 1 day visit 1 , eligible subject recruit first evaluation perform ; visit 1 , baseline injection perform ; visit 2 , 30 +/- 3 day injection , evaluation perform ; visit 3 , 90 +/- 3 day injection , evaluation perform ; 4 , 120 +/- 3 day injection , evaluation perform ; visit 5 , 150 +/- 3 day injection , evaluation perform . Assessment percentage ( % ) responder , 5 month injection , effect two BT-A preparation , Dysport® Xeomin® , measure frontalis m. wrinkle intensity maximum contraction , measure visual Wrinkles Severity Scale ( WSS ) .</detailed_description>
	<mesh_term>abobotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins , Type A</mesh_term>
	<mesh_term>onabotulinumtoxinA</mesh_term>
	<mesh_term>incobotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins</mesh_term>
	<criteria>Subject agreement provide write informed consent willingness ability comply aspects protocol ; Female subject ; Phototype I IV ; Subjects age 18 60 year ; Subjects naive BTA treatment ; Subjects present degree moderate ( 2 ) severe ( 3 ) wrinkle leave right side forehead maximum voluntary contraction frontalis m. accord WSS ; Subjects Minor 's test showing least grade III Sweating Intensity Visual Scale ; Medical history physical examination , base investigator 's opinion , prevent subject take part study make use product investigation ; Subjects childbearing age present negative urine pregnancy test baseline use highly effective contraceptive method study ; Availability subject throughout study ( 5 month ) ; Subject agree undergo cosmetic dermatological procedure participation study ; Subjects sufficient school knowledge enable cooperate degree require protocol . Pregnant woman woman intend become pregnant follow 5 month screen ; Lactation period ; Subjects participate clinical trial ; Any prior surgery affect frontalis and/or orbicularis muscle , prior blepharoplasty brow lift ; Any prior cosmetic procedure , include filler , scar may interfere study result ; Subjects neoplastic , muscular neurological disease ; Subjects take aminoglycoside penicillamine antibiotic , quinine Ca2+ channel blocker ; Subjects inflammation active infection area inject ; Subjects present evident facial asymmetry ; Subjects history adverse effect , sensitivity component study drug formula , ptosis adverse effect , investigator 's opinion , prevent subject participate study ; Subjects present Myasthenia Gravis , EatonLambert Syndrome motor neuron disease ; Subjects coagulation disorder take anticoagulant ; Subjects know systemic autoimmune disease ; Subjects history nonadherence medical treatment show unwillingness adhere study protocol ; Any condition , opinion investigator , compromise evaluation study .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>July 2014</verification_date>
	<keyword>botulinum toxin ,</keyword>
	<keyword>wrinkle</keyword>
</DOC>